[Effect of a new beta-blocking drug (SP/1601) on the extension of experimental acute infarct in anesthetized dogs].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D004353:Drug Evaluation, Preclinical; D004562:Electrocardiography; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy*; D011412:Propanolamines / Q000008:administration & dosage / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines
Effetti di un nuovo farmaco beta-bloccante (SD/1601) sulla estensione dell'infarto acuto sperimentale nel cane narcotizzato.